After more than a decade of development in flow diversion therapies, the fourth generation Pipeline™ Vantage embolization device with Shield Technology™ continues the legacy by providing meaningful innovation in biomaterial science and technology.
Improvements to both the device and delivery system provide more control during navigation, deployment, and re-sheathing so you can achieve a precise delivery, when treating aneurysms near and far.
Find more information, including other available configurations, for Pipeline™ Vantage embolization device.